"Logistics reform is industrial policy by other means." Examine with reference to recent steps for the pharmaceutical and medtech sectors.

Classic industrial policy uses tariffs, subsidies and licensing. Logistics reform shapes the same things by changing what it costs, and how long it takes, to move goods: where firms locate, what they import and how fast they grow. The Health Ministry's proposal of 10 new import points for drugs, medical devices and cosmetics (8 ICDs, 1 SEZ and Noida International Airport) [1] shows that this claim holds, but only in part.

How logistics reform acts as industrial policy

• Clearance close to clusters: The proposed points at Sonipat and Dadri (NCR), Sanath Nagar and Thimmapur (Hyderabad), and Whitefield and SEZ Bommasandra (Bengaluru) [1] would clear customs near manufacturing hubs. In effect, this is a location incentive.
• Cheaper inputs: Faster, lower-cost access to imported APIs and components helps firms that make finished medicines and assemble devices, many of them for export. It works like an input subsidy without any money from the budget.
• Supply resilience: Using Noida International Airport for drug imports by air [1] speeds up high-value, time-sensitive cargo and reduces stock-outs.
• Support for PLI: The PLI schemes for bulk drugs and medical devices began when India imported about 90% of its medical devices [3]. They need efficient logistics for both inputs and exports.

Where the claim falls short

• Conflict with Atmanirbhar: Easier imports make foreign APIs and devices cheaper. That hurts new PLI plants, which need years to build [3].
• Regulatory capacity is the real constraint: Every port needs CDSCO officers and sampling. A Rajya Sabha committee flagged a shortage of drug inspectors and testing facilities in 2008 [4]. In 2026, the Standing Committee found that Drugs Controller vacancies were still slowing CDSCO [2].
• Quality risk: More entry points create more openings for substandard or falsified products if checks are uneven.

Logistics reform therefore enables industrial policy but cannot replace it. It lowers transaction costs, but it cannot by itself build domestic capacity or guarantee quality. Three steps would let these ports serve industrial goals:

• open a port only once its regulatory staff are in place;
• recruit CDSCO staff on a fixed timeline and empanel accredited labs, as the Standing Committee recommended [2];
• match import facilitation to PLI timelines.

Done this way, the reform would advance Atmanirbhar Bharat and SDG 3's goal of safe, affordable medicines.